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FurazolidoneSelf-assembly and solubilization properties of amphiphilic mono- and bisquaternized derivatives of 1,4-
diazabicyclo[2.2.2]octane (mono-CS-n and di-CS-n, where CS – cationic surfactant, n=12, 14, 16, 18)was inves-
tigated by nuclear magnetic resonance with magnetic ﬁeld pulse gradient. The inﬂuence of Dabco-surfactant
structure (head group and length of alkyl chains) on critical micelle concentration and aggregation number of
micelles was studied. The CMC of mono-CS-n are lower than CMC of di-CS-n. The aggregation numbers of
mono-CS-n micelles are higher than for di-CS-n micelles. The solubilization capacity of mono-CS-n is higher
than di-CS-n. The solubilization capacity of mono-CS-16 is 2.5 times higher than CTAB in the case of Orange
OT as a solute, and it is close to CTAB in the case of Sudan I. The solubility of a poorly water-soluble antibacterial
drug furazolidonewas improved bymicellar solubilization based onmono- and di-Dabco-surfactants. Mono-CS-
n is the best solubilizing agents toward furazolidone. The use of mixed composition mono-Dabco-16-furazoli-
done provides a signiﬁcant increase in antimicrobial activity (by 2 times against bacteria and 8 times against
fungi) and reduces by 2 times the dose of each of the components in combination formulation and causes b2%
haemolysis of human red blood cells at the active dose.
© 2018 Elsevier B.V. All rights reserved.1. Introduction
It is well known that cationic amphiphiles are vectors for gene trans-
fection [1,2] and antimicrobial agents [3,4]. Recently, great attention has
been paid to the development of positively charged particles, as new
targeted delivery systems with improved stability, selectivity, and
other properties [5–7]. The interactions of positively charged particles
result in improved ocular bioavailability [8–10], skin penetration
[11–13] and intranasal mucosal delivery [14]. Inﬂammatory activation
of liposomes depends not only on the charge but also in the cationic sur-
factant structure [15]. Starting with the ﬁrst and second generations of
cationic charged liposomes [16], preclinical and clinical results testify
the promising cationic liposomal therapy in the future [17,18].rganic and Physical Chemistry,
Arbuzov, 420088 Kazan, Russia.
irova).However, as a rule, surface potential is a source of cytotoxicity. There-
fore, it is important to ﬁnd a compromise between beneﬁts and toxicity
of cationic surfactants. The synthesis of new non-toxic materials was
performed and a new approachwas implemented to improve the safety
of delivery systems. For this purpose, сationic surfactants with low crit-
ical micelle concentrations such as gemini (dimeric) surfactants are the
most attractive [19–26]. Cationic amphiphiles containing natural frag-
ments, such as sugar- [27,28], peptide- [29,30] pyrimidine- [31,32]
and amino acid-surfactants [33], biodegradable amphiphiles [34] are
also promised. The long-chain cetalkonium chloride-cationic emulsions
are attractive for reducing toxicity of cationic surfactants and for further
development in eye drops [35] The increase of the antimicrobial efﬁcacy
by cationic nanoemulsions was shown [36].
Our research group focused on amphiphilic derivatives of 1,4-
diazabicyclo[2.2.2]octane (Dabco) [37–39]. Some interesting features
in self-assembly behavior and functional activity (high catalytic effect,
solubilization properties, antimicrobial activity) of Dabco-surfactants
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Dabco is less toxic than the classic surfactant, cetyltrimethylammonium
bromide, CTAB [41]. In addition, the hexadecyl derivative of Dabco is
non-toxic in the presence of N-methyl-D-glucamine and has an antimi-
crobial activity [39].
This work was aimed at improving the solubility of a poorly water-
soluble drug furazolidone by micellar solubilization of mono- and dica-
tionic Dabco surfactants (Fig. 1). Furazolidone is an antibacterial drug
against both gram-positive and gram-negative bacteria, used as a topi-
cal surface skin active component in prevention and treatment of burn
wound infections. The bioavailability of furazolidone was improved by
adding organic solvents and hydrotropes [44]. To avoid toxicity,
furazolidone-loaded liposomal forms were prepared [45] and interac-
tion with dimyristoylphosphatidylcholine was studied [46]. Liposomal
forms of furazolidone open prospects against leishmaniasis [47] and
Helicobacter pylori [45]. The process of micellar solubilization involves
several factors [48]: the structure of surfactants (solubilizer) [49,50],
the aggregation number [51], and the size and geometry of micelles
[52]. A drug can be solubilized, not only in the inner core micelle by hy-
drophobic effect, but also in the peripheral area of micelle [53,54] by
electrostatic and hydrogen bondingwith the head groups of surfactants.
The goal of this work was to establish the relationship between
Dabco-surfactant structures, aggregation number of micelles and solu-
bilization properties toward poorly water-soluble optical dyes and an
antimicrobial drug (furazolidone). Biological activity and toxicity analy-
sis were performed for creation of non-toxic antimicrobial formulations
based on derivatives of Dabco and furazolidone.
2. Materials and methods
2.1. Materials
Monocationic surfactants were prepared by reaction of Dabco with 1-
bromoalkyles. Dicationic surfactants of 1,4-diazabicyclo[2.2.2]octane
were made by quarterization of mono-CS with ethyl bromide. All details
about syntheses were described earlier [38]. N-Methyl-D-glucamine
(99%, ACROS Organics, NJ, USA), cetyltrimethylammonium bromide
(CTAB, 99%, DK, Acros), 1-(o-tolylazo)-2-naphthol (75%, Orange OT, Al-
drich, USA), 1-phenylazo-2-naphthol (Sudan I, Acros Organics), furazoli-
done (98%, Alfa Aesar, Heysham, England), hexamethyldisiloxane
(HMDSO, Aldrich), Triton-X-100 (ACROS Organics, NJ, USA), Sodium do-
decyl sulfate (SDS, 99%, ACROSOrganics, NJ, USA)were used as purchased.
2.2. Methods
2.2.1. Tensiometry
Surface tension measurements were performed using the du Nouy
ring detachment method (Kruss K6 Tensiometer, Hamburg, Germany).Fig. 1. Structural formulas of cationic surfactants, mono-(mono-CS-n) and bisquaternary (di-CS
18), cetyltrimethylammonium bromide (CTAB), hydrophobic dyes (Orange OT, Sudan I) and dBrieﬂy, the spherical ring was placed parallel to the air/water interface.
Between two surface tension measurements, the ring was cleaned with
Ultra-pure water, followed by soaking in ethanol for 5–7 min, rinsing
again with Ultra-pure water, and ﬁnally ﬂame-drying. Temperature
was kept constant at 25 °C during all experiments.
2.2.2. Conductometry
Speciﬁc conductivity was measured using a WTW InoLabCond 720
precision conductivity meter (WTW GmbH, Weilheim, Germany). All
measurements were carried out at 25 °C. Puriﬁed water (18.2 MΩ cm
resistivity at 25 °C) from Direct-Q 5 UV equipment (Millipore S.A.S.
67120 Molsheim-France) was used for all sample preparations.
2.2.3. Spectrophotometry (dye and drug solubilization)
Solubilization of dyes (Orange OT, Sudan I) was performed by
adding an excess of crystalline dyes to surfactant solutions. These solu-
tionswere allowed to equilibrate for about 48 h at 25 °C, followed by ﬁl-
tration. Then the absorbance wasmeasured at 495 nm (Orange OT) and
in the range 483–492 nm (Sudan I) on a spectrophotometer Specord
250 Plus (Analytik Jena AG, Germany). Quartz cuvettes (1 cm path
length) were used. The solubilization capacity of associates (S), which
corresponds to the number of moles of dye solubilized per mole of sur-
factant, was determined according to Eq. (1) [55]:
S ¼ B= εext  1ð Þ ð1Þ
where В is the slope of the dye absorbance as a function of surfactant at
concentration above the critical micelle concentration (CMC) and εext is
the extinction coefﬁcient of Orange OT (εext = 18720 M−1 cm−1) [56]
and the extinction coefﬁcient of Sudan I (εext = 8700 M−1 cm−1) [57].
2.2.4. Particle size analysis
Size, zeta potential and polydispersity index of nanoparticles were
determined by dynamic light scattering (DLS) measurements, using
the Malvern Instrument Zetasizer Nano (Worcestershire, UK). Mea-
sured autocorrelation functions were analyzed by Malvern DTS soft-
ware, applying the second-order cumulant expansion methods. The
effective hydrodynamic radius (RH) was calculated according to the
Einstein-Stokes equation D = kBT / 6πηRH, where D is the self-
diffusion coefﬁcient, kB is the Boltzmann constant, T is the absolute tem-
perature, and η is the viscosity. The diffusion coefﬁcient was measured
at least three times for each sample. The average error ofmeasurements
was 4%. All samples were diluted with ultra-pure water to suitable con-
centration, and then, analyzed in triplicate.
2.2.5. NMR experiments for micellization study
Sample preparation for measurement of self-diffusion coefﬁcients
(SDC) are described earlier [40,58,59]. The solvent for surfactant-n) ammoniumderivative of 1,4-diazabicyclo[2.2.2]octane (Dabco-nwhere n=12, 14, 16,
rug (Furazolidone).
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solutions were measured by using a Bruker AVANCE 400 NMR-
spectrometer using a pulsed magnetic ﬁeld gradient (G) of up to
0.53 Tm−1. TheD values were derived from the decrease in the integral
intensity of stimulated spin echo signals from protons of the different
groups of alkyl and cyclic moieties of surfactants (Eq. (2)). These signals
are due to changes in the ﬁeld gradient in a series of three consecutive
90° pulses:
I Gð Þ ¼ I0 exp − γδGð Þ2D Δ−δ3
  
ð2Þ
In Eq. (2), γ is the gyromagnetic ratio of proton, δ is the gradient
pulse duration, and Δ is the time interval between gradient pulses. De-
pending on the self-diffusion coefﬁcient the values of δ and Δ varied
from6 to 10ms and from50 to 70ms, respectively. These times are sub-
stantially longer than the time needed for exchange of molecules be-
tween free and micellar components of the solution.
The SDC values were averaged from proton resonance signals of the
different atomic groups of alkyl and cyclic moieties of surfactant. The
error in SDC measurement at high surfactant concentration was about
2%, at low concentration - about 5%. The experimental studies were car-
ried out at 25 °C controlled by the thermostabilized systemof spectrom-
eter. The concentration dependence of the SDC of surfactant molecules
was simulated by using a pseudo-phase model of micellization, in
which the critical micelle concentration is considered as a transition
point between monomer (free) and aggregated states of surfactant in
solution.
At concentration exceeding CMC, there is a fast exchange between
free surfactant molecules and micellar surfactant molecules, so that
the observed SDC of surfactant molecules Dobs represents the average
quantity weighted between the SDC of these components:
Dobs ¼ pf Df þ pmDm ð3Þ
where pf, Df and pm, Dm are the weights and the SDC of free andmicellar
components of surfactant in solution.
The concentration of free pf and micellar pm components of surfac-
tant can be expressed by Eq. (4) from the total concentration of surfac-
tant in solution Dt, the observed SDC Dobs, the SDC of free molecules Df,
and the SDC of surfactant forming the micelles Dm:
pf ¼ 1−pm ¼ Dt−Dmð Þ= Df−Dm
  ð4Þ
The SDC of free molecules were calculated from Eq. (5) [59]:
Df ¼ Df ;CMC 1þ
φ
2
 	−1
ð5Þ
where Df,CMC is the SDC of free molecules of surfactant near CMC and φ
is the volumetric fraction of micellar surfactant. φ is determined by the
Eq. (6):
φ ¼ Mef Ct−CMCð Þ=ρV ð6Þ
whereMef is the effectivemass of surfactant micelles, Mef= 500, deter-
mined taking into account the degree of binding with the counter-
micelle (β) from [38], Ct is surfactant concentration in solution, ρ is
the density of the micellar surfactant, V is volume of the solution.
Hexamethyldisiloxane (HMDSO) was used as a micellar solubilized
molecule in order to determine the SDC of micelles. HMDSO molecules
penetrate into micelles and diffuse together with them. Assuming that
the presence of the HMDSOmolecules in micelles does not cause nota-
ble errors in SDC and size of micelles at low concentration of HMDSO
(CHMDSO ≪ Csurf), the SDC Dm was measured from the decay of NMR
line attributed to HMDSO protons.The aggregation numbers of micelles were estimated using the ratio
of “dry”micelle volume Vm=4πR3 / 3, to volume of the surfactantmol-
ecule, Vmol=Мef / ρNA, where, ρ – is the surfactant density inmicelle (it
is considered that density is close to that of surfactant in solid state
103 kg/m3). The values of micelle SDC near CMC were estimated by ex-
trapolation of the concentration dependence of Dm to the zero concen-
tration of micelles. This extrapolation was performed on purpose of
using the viscosity of the pure solvent in calculations.
Results obtained can be used to estimate the number of surfactant
and solubilizate (Furazolidone) molecules in micelles [41]. The volume
of a micelle (Vm) is the sum of volumes occupied by surfactant (VSurf)
and solubilizate (VFur).
Vm ¼ Vsurf nsurf þ VFurnFur ð7Þ
where VSurf=Mef Surf / (ρSurfNA) is the volumeoccupied by the surfactant
molecule, VFur = MFur / (ρFurNA) is the volume occupied by the
solubilizate molecule in the micelle, Mef Surf andMFur are the molecular
masses of surfactant and solubilizate, Mfur = 225, ρSurf and ρFur are the
densities of surfactant and solubilizate, nSurf and nFur are the numbers
of surfactant and solubilizate molecules in the micelle. With consider-
ation to Nagg = nSurf + nFur, Eq. (8) can be rewritten as follows:
Vm
Nagg
¼ Msurf
ρsurf NA
nsurf
nsurf þ nFur
þ MFur
ρFurNA
nFur
nsurf þ nFur
ð8Þ
If formula (8) is supplementedwith a solubilization factor deﬁned as
β= nFur / nSurf= Cm,Fur / Cm,Surf, where Cm,Fur and Cm,Surf are the concen-
trations of solubilizate and surfactantmolecules inmicelles, then the ex-
pression for the micelle aggregation number takes the form.
Nagg ¼ VmNA 1þ βð Þ= Msurf =ρsurf þ MFur=ρFurð Þβ
j k
ð9Þ
Finally, the number of solubilizate molecules in micelles was calcu-
lated by the formula nFur = Nagg / (1 + 1 / β).
2.3. Antibacterial and antifungal activity
In vitro antibacterial and antifungal activities of cationic surfactants
and their compositions were evaluated against pathogenic representa-
tives of Gram-positive bacteria Staphylococcus aureus АТСС 209p (Sa)
and fungi Candida albicans NCTC 885-653 (Ca). Minimal inhibitory con-
centrations (MICs) were estimated by conventional dilution methods
for bacteria and fungi [60]. The antibacterial and antifungal assays
were performed in Hottinger broth (HiMe-dia Laboratories Pvt. Ltd.
Mumbai, India) and Sabouraud dextrose broth (HiMedia Laboratories
Pvt. Ltd. Mumbai, India) (bacteria 3 × 105 cfu/mL and yeast 2
× 104 cfu/mL). The components of Hottinger broth (Lactalbumin hydro-
lysate (10 g), Peptone (10 g), NaCl (5 g)) were dissolved in 1 L of dis-
tilled water, autoclaved for 20 min at 121 °C. The pH was adjusted to
7.2 prior to autoclaving. The components of Sabouraud dextrose (Pep-
tone (10 g), glucose (40 g)) were dissolved in 1 L of distilled water,
autoclaved for 15 min at 121 °C. The pH was adjusted to 5.6 prior to
autoclaving. The tests were repeated 3 times.
2.4. Hemolytic activity assay
Toxicity of cationic surfactantswas tested for their hemolytic activity
against human red blood cells (hRBC). Fresh hRBC collected from hepa-
rinized blood were rinsed 3 times with 35 mM phosphate buffer con-
taining 0.15 M NaCl, pH 7.3 (PBS). Each time, the suspension was
centrifuged for 10min at 800g, the supernatant discarded, and the pellet
re-suspended in PBS. Test compound dissolved in PBS (concentrations
0.98–500 μg/mL) were then added to 0.5 mL of a suspension of hRBC
in PBS to reach a ﬁnal volume of 5 mL (ﬁnal erythrocyte concentration
was 10% v/v). The resulting suspension was incubated under gentle
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for 10 min. The release of hemoglobin from hRBC was monitored by
measuring the supernatant absorbance at 540 nm. Controls for zero he-
molysis (blank) and 100% hemolysis consisted of hRBC suspended in
PBS and distilled water, respectively.
3. Results and discussion
3.1. Self-assembled properties and aggregation number of Dabco-
surfactant micelles
The self-assembly of Dabco-surfactants was studied usingNMRwith
magnetic ﬁeld pulse gradient (NMR-MFPG) to understand the inﬂuence
of Dabco-surfactant structure (head groups and length of alkyl chains)
on the CMC and aggregation number of micelles. The dependence of
self-diffusion coefﬁcients on the concentration of surfactants is shown
in Figs. 1S–3S. CMCs were determined from the dependence of Dobs on
the reciprocal of concentration, 1/Сt, according to [61]. The values of
the CMC are presented in Fig. 2a. Nagg for mono-CS-n and di-CS-n are
shown in Fig. 2b and c, respectively.
It can be seen, that the CMC decreases linearly with increasing the
length of alkyl chains of Dabco-surfactants from dodecyl to octadecyl
homologues by 2 orders, and 30 times for mono-CS-n and di-CS-n, re-
spectively. There is a good linear dependence with correlation coefﬁ-
cients (0.998, 0.995) for mono-Dabco and di-Dabco-surfactant series,
respectively. Slopes are decreasing from monocationic Dabco-n (0.35)
to dicationic surfactants (0.254). Likely, the increase in CMC difference
between mono-CS-n and di-CS-n (Fig. 2a) is due to more unfavorable
thermodynamic process of di-CS-n micelle formation compared to
mono-CS-n. The CMC of mono-CS-n are lower than CMC of di-CS-n
with the same alkyl chain. This indicates that the polarity of these
mono-Dabco and di-Dabco-surfactants are different. It is plausible that
the electrostatic repulsion between the headgroups of di-CS-n is much
stronger than formono-CS-n. The values ofNagg support this hypothesis.
Aswe can see in Fig. 2b and c, Nagg decreases upon increasing size of sur-
factant head group. By tensiometry, it was found that the minimal sur-
face area per mono-CS-n surfactant molecule is less than per di-CS-n
surfactant [38]. The reduction of mutual repulsion in micelle permitsFig. 2. CMC of Dabco-surfactants (a); aggregation number of micelles for mono-CS-n (b) ancloser packing of the head groups, leading to a signiﬁcant increase in
Nagg. This trend remains with increasing the chain length of mono-CS-
n surfactants. Usually Nagg increases with growing alkyl chain length
in the homologous series of classical surfactants (n-
alkyltrimethylammonium bromides and chlorides) and imidazolium
ionic liquids [62–65].
Nagg increase with increasing mono-CS-n and di-CS-n surfactant
concentrations. Nagg of mono-CS-14 and di-CS-14 surfactants in our
present work are in good agreement with values obtained by means
of ﬂuorescence techniques earlier [38,59]. In numerous works, micelle
aggregation numbers of typical cationic surfactants are concentration
independent in the range extending from the CMC to 0.1 M and even
above for certain investigated surfactants [64–66]. However, spherical
micelles with variable aggregation numbers were also reported in liter-
ature [67,68]. Increasing Nagg with concentration can be explained by
several hypotheses. The variable character of their Nagg is obvious for
non-spherical micelles. The increase of Nagg with concentration could
indicate that the spherical micelles present at low concentration change
shape at higher concentration [69]. Amuch stronger tendency formicel-
lar growth and formation of aggregates of lower curvature and forma-
tion of threadlike micelles for gemini surfactants was shown [70].
Increase in the polydispersity index of systems and formation of two
types of aggregates could also be the cause [71].3.2. Micellar solubilization of poorly water soluble dyes and drug
(furazolidone)
Absorption spectra of poorly water-soluble dyes (Orange OT and
Sudan I) in Dabco-surfactant solutions are presented in Figs. S4–S15.
The optical density increases with increasing surfactant concentration
for all Dabco-surfactants. Fig. 3 shows the absorption of dyes in
Dabco-surfactant solutions at λmax. The increase in absorption above
CMC is associated with the solubilization of the dye in the hydrophobic
core of surfactant self-assembled structures. In the case of di-CS-n
(Fig. 3b, c), the increase of optical density is observed at concentrations
below CMC di-Dabco-n surfactants. Despite the fact that the structure of
both azo dyes is very similar, the formation of surfactant-Sudan Id di-CS-n (c), where n= 12a (1), 14 (2), 16 (3), 18 (4) at 30 °С. a - Data from ref. [58].
Fig. 3. Absorbance of Orange OT (a) and Sudan I (b, c) in surfactant solutions, at λmax =
495 nm (a), 483–492 nm (b, c), L = 1 cm.
Fig. 4. Solubilization capacity of surfactants toward hydrophobic dyes Orange OT and
Sudan I as a function of the number of carbon atoms of mono-Dabco and di-Dabco-
surfactants.
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ibility of Sudan I compared to Orange OT.
Solubilization capacity data, calculated through formula (1) are pre-
sented in Fig. 4. Solubilization ability allows one to quantify the ability of
surfactants to solubilize the hydrophobic dye. Solubility of dyes linearly
increases with alkyl chain length of CS-n and follows the relations:
S ¼−0:0899þ 0:00843n; r ¼ 0:997 Orange OT in mono−CS−n solutionð Þ;
S ¼−0:2096þ 0:0195n; r ¼ 0:997 Sudan I in mono−CS−n solutionð Þ;
S ¼−0:08767þ 0:00902n; r ¼ 0:97 Sudan I in di−CS−n solutionð Þ:
The solubilizing capacity depends on both surfactant chain length
and nature of surfactant head group. Unlike mono-CS-n, the decrease
in solubilization capability of di-CS-n with the same alkyl chain may re-
sult from their lower aggregation numbers and lower packaging in di-
CS-n micelles. The incorporation of solubilizate in the hydrocarbon
core of micelles is the result of the hydrophobic effect, but also of ad-
sorption through other non-covalent interactions between dye and sur-
factant. It should benoted that the solubilizing properties dependon the
nature of the solubilizate. The solubilization capacity of mono-Dabco
surfactant is much higher with Sudan I than with Orange OT assolubilizates. The structure of dyes plays an important role in determin-
ing the solubilization capacity [72]. Further, the solubilization capacity
of Dabco-surfactants with a hexadecyl chain and the classical surfactant
cetyltrimethylammonium bromide (CTAB) were compared. In the case
of Orange OT as a solute, the solubilization capacity of mono-CS-16 is
2.5 times higher than that of CTAB (S = 0.0159 [57]). In the case of
Sudan I as a solubilizate, the solubilization capacity of mono-CS-16
and the solubilization capacity of CTAB (S = 0.107 [73]) are very close.
The solubility of furazolidone in different surfactant solution is
shown in Fig. 5.
The concentration of solubilized furazolidone was calculated from
the absorbance values with the aid of a calibration curve in organic sol-
vent. Furazolidone is slightly soluble inwater (solubility of 0.25mM). As
can be seen in Fig. 5, furazolidone dissolves better in cationic surfactant
solutions. The solubility of furazolidone at 5 mM surfactant is 1.2 times
better in CTAB solutions, 1.4 times better in mono-CS-16 solutions and
1.25 times better in di-CS-16 solutions than in water. The same solubil-
ity of furazolidone inmono-CS-12 and in SDS solutions is observed for a
concentration of surfactants by 10 times higher. An increase of drug sol-
ubilitymay occur in the case of formation ofmixed drug-surfactant self-
assemblies. The micellization properties and thermodynamics of mi-
celle formation may change in the presence of drugs [74–79]. The effect
of furazolidone on the CMC of surfactant solutions was analyzed by ten-
siometry and conductometry. The surface tension isotherms of surfac-
tant solutions in the absence and presence of furazolidone are
presented in Fig. 6.
CMC of surfactants do not change in the presence of furazolidone,
except for SDS. For SDS, the shift of CMC to lower concentrations and
a decrease of surface tension are observed. This could be the result of
different mechanism of binding furazolidone with anionic and cationic
Fig. 5. Solubility of furazolidone as a function of surfactant concentration, Triton-X-100
(1), CTAB (2), SDS (3), mono-CS-16 (4), di-CS-16 (5), mono-CS-12 (6) pH 6.0, 25 °С.
Fig. 6. Surface tension isotherms of surfactant solutions of Triton-X-100 (1, 2), SDS (3, 4),
CTAB (5, 6),mono-CS-16 (7, 8),mono-CS-12 (9, 10), di-CS-16 (11, 12) in the absence (1, 3,
5, 7, 9, 11) and presence (2, 4, 6, 8, 10, 12) of furazolidone, 25 °С.
Table 1
CMC determined by tensiometry (Tens) and spectrophotometry (Spectr) and adsorption
parameters for micellar surfactant systems in the absence and presence of furazolidone
(Fur).
Systems CMC,
mM
CMC,
mM
106 Гmax,
mol m−2
Аmin,
nm2
ΔGad, kJ
mol−1
ΔGmic, kJ
mol−1
Spectr Tenz
CTAB – 1 2.48 0.67 −49.5 −36.1
CTAB/Fur 2 1 3.1 0.536 −41.9 −31.4
Mono-CS-16a – 1 2.37 0.70 −46.6 −34.1
Mono-CS-16/Fur 0.7 1.1 3.24 0.513 −42.4 −32.9
Di-CS-16 – 3 2.29 0.726 −33.5 −23.0
Di-CS-16/Fur 3 3.5 1.63 1.019 −38.3 −23.4
SDS – 8 2.46 0.676 −38.3 −22.1
SDS/Fur 6 7 2.5 0.66 −41.1 −24.3
a Calculation according to ref. [38].
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this behavior at air-water interface. Adsorption parameters determined
from adsorption and conductometric data are presented in Table 1.
The values of surface excess (Гmax), the surface area per molecule
(Amin); the standard free energy of micellization per mole of monomer
unit (ΔGm) and the standard free energy of interfacial adsorption at
the air/saturated monolayer interface (ΔGad) were calculated using
Eqs. (7)–(11) [80–83]. Therefore, the constant m= 2was used for mo-
nomeric ionic surfactant, where the surfactant ion and the counterion
are univalent, while m = 3 was assumed for dicationic surfactants.
This issue is thoroughly discussed in ref. [82].
Γmax ¼− 12:3mRT lim dπ=dlogCð ÞC→cmc
ð7Þ
Аmin ¼ 1018= NA  Гmaxð Þ ð8Þ
ΔGad ¼ ΔGm− πCMC=Гmaxð Þ ð9Þ
ΔGm ¼ RT 1þ βð Þ ln CMCð Þ; ð10Þ
ΔGm ¼ RT 0:5þ βð Þ ln CMCð Þ− RT ln2ð Þ=2½  ð11Þ
Adsorption parameters, the values of surface excess and minimum
surface area per molecule at the interface, Amin, suggest the formation
of closely packed monolayer at the air-solution interface except for di-
CS-16. The ΔGmic values for di-CS-16/furazolidone and SDS/furazoli-
done mixed systems become increasingly more negative compared to
pure surfactant. This indicates that micelle formation in mixed systemsis easier. Likely, solubility of furazolidone is due to a combination of dif-
ferent mechanisms, including electrostatic and speciﬁc interactions
with surfactants.
The formation of particles of size about 200 nmwithin the region of
concentration 0.08–1.5 mM for cationic surfactants-furazolidone and
about 80 nm for the SDS/furazolidone system within the region of
Fig. 7. Particle size distribution (a) using the number parameters for SDS/furazolidone (2 mM) and CTAB/furazolidone (0.08 mM) and zeta-potential (b) of CTAB/furazolidone (1), SDS/
furazolidone (2) and mono-CS-16/furazolidone (3) mixed systems, 25 °С.
Fig. 8. The self-diffusion coefﬁcient of cationic surfactant di-CS-16 in absence (1) and in
the presence furazolidone (3), furazolidone (2) vs. surfactant concentration (A) and
reciprocal concentration (B) at 30 °C (CFur = 0.4 mM).
7T.N. Pashirova et al. / Journal of Molecular Liquids 296 (2019) 112062concentration 2–8 mM was established by dynamic light scattering
(Fig. 7a).
A change in surface charge (zeta potential) of self-assembling
surfactant-furazolidone structures from negative to positive with in-
creasing surfactant concentration conﬁrmed the formation of mixed
structures (Fig. 7b). Zeta potential is changed and pre-micellar drug/
surfactant structures are observed below the CMC. A high polydispersity
of solutions N0.5 and additional aggregates of 2–3 nm size are observed
at concentration above CMC.
Plots showing diffusion coefﬁcients D of surfactant di-CS-16 and
solubilizate (furazolidone) in D2O vs. total concentration (A) and recip-
rocal total concentration (B) of surfactant Ct are shown in Fig. 8.
The SDC of surfactant is practically constant and close to the value of
SDCCMC at concentration below the CMC. It indicates that the inﬂuence
of the interaction of surfactantmoleculeswith each other on their trans-
lational motion is very weak. In contrast, the SDC of furazolidone is not
constant and decreases with increasing surfactant concentration, ap-
proaching the SDC of surfactant molecules at CMC. It can be stated
that this is an effect of surfactantmolecules on themovement of furazol-
idonemolecules and the formation of premicellar associates surfactant-
furazolidone. The concentration dependences of the SDС of surfactant
molecules in the absence and in presence of furazolidone and furazoli-
done, are the same in concentration range above CMC. All of parameters
calculated using Eqs. (3)–(9) are presented in Table 2.
It can be seen that increasing concentration of surfactant in solution
increases the relative fraction of surfactant molecules in micelles, the
total concentration ofmicelle bound furazolidonemolecules, and the ra-
dius and aggregation number of micelles but decreases the number of
solubilizate molecules in micelles. The self-diffusion coefﬁcient values
and aggregation number of micelles in the absence and presence of
solubilizate above CMCare almost the same. The difference in the aggre-
gation numbers is high when the number of solubilizate molecules in
surfactant micelles is high. Likely, in this case drug-surfactant micelles
are looser than empty surfactant micelles. This indicates that
solubilizate almost does not affect the size and the shapes of micelles.
The partition coefﬁcient of the solubilizate between the micellar and
aqueous phases determined from the ratio of correspondingmolar con-
centrations: Cm,fur / (Ctotal,fur− Cm,fur) [84], where Ctotal,fur is the total
concentration of furazolidone (0.4 mM). It can be seen in Fig. S16 that
the fraction of furazolidone bound micelles on the initial segment of
the plot is a linearly increasing function of surfactant concentration
Table 2
Parameters of di-CS-16 in the presence and in absence furazolidone, where nFur is the numbers of solubilizate molecules, D2O at 30 °C.
Ct, mM Cm surf, mM Cm Fur, mM D, sm2/s R (Ra), nm β Nagg (Nagga) nFur
4
1.42 0.132 8.2 × 10−7 2.6 (3.04) 0.093 92 (138) 9
6
3.35 0.223 8.0 × 10−7 2.6 (3.06) 0.067 97 (144) 6
8
5.41 0.27 7.8 × 10−7 2.7 (3.05) 0.05 104 (143) 5
10
7.3 0.292 7.6 × 10−7 2.8 (3.06) 0.04 113 (145) 4
20
18.23 0.364 7.3 × 10−7 2.9 (3.12) 0.02 120 (153) 2
40
38.33 0.382 6.8 × 10−7 3.02 (3.16) 0.01 140 (160) 1
a The hydrodynamic radius of micelles of surfactant in absence furazolidone.
Table 3
Antibacterial and antifungal activities of surfactant, furazolidone (Fur) and their mixed micellar systems.
Systems Ratio
Surf/drug
Bacteriostatic and
fungistatic activity
(μg·mL−1)
Bactericidal and fungicidal
activity (μg·mL−1)
Haemolysis of human red blood cells (%)
Sa Ca Sa Ca The concentration of system (μg/mL)
0.48 0.98 1.8 3.9 7.8 31.3
Mono-CS-16 [39] 100/0 0.48 ± 0.05 3.1 ± 0.3 0.98 ± 0.1 6.3 ± 0.6 0 – – 2.8 – –
Fur 0/100 0.98 ± 0.09 31.3 ± 3 0.98 ± 0.1 31.3 ± 3 0 0 0.2 0.43 0.3
Mono-CS-16/Fur 50/50 0.48 ± 0.05 3.9 ± 0.4 0.48 ± 0.05 7.8 ± 0.78 0 0.2 0.9 1.8 8.6 51.2
Mono-CS-16/Fur/NmDg 25/50/25 1.9 ± 0.02 7.8 ± 0.8 1.9 ± 0.02 15.6 ± 1.5 0 0 0 0.8 0.63 100
8 T.N. Pashirova et al. / Journal of Molecular Liquids 296 (2019) 112062until 10 mM. The partition coefﬁcient calculated from the slope of the
linear segment, considering Vsurf = 0.3 L/mol is 1223.
3.3. Biological activity
The antimicrobial activity of mono-CS-16, furazolidone and their
mixed systemswas tested against a gram-positive bacteria Staphylococ-
cus aureus АТСС 209p (Sa) and a fungus Candida albicans/NCTC 885-653
(Ca). Theminimum inhibitory concentrations (MIC), theminimal bacte-
ricidal concentrations (MBC) and theminimal fungicidal concentrations
(MFC) are reported in Table 3. The combination of furazolidone with
mono-Dabco-16 cationic surfactant improves antimicrobial activity
(bacterial in 2 times and fungistatic in 8 times) with reducing their
dose. It is known that furazolidone binds bacterial DNA [85,86] It is
probablemono-Dabco-16 surfactant can facilitate themechanism of ac-
tion of furazolidone, for example, by internalization into microbial cells.
The toxicity of mixed systems against human red blood cells is b2% at
active dose and even less toxic in the presence N-methyl-d-glucamine
(NmDg) additive.
4. Conclusions
Self-assembly of mono- and dicationic Dabco-surfactants was inves-
tigated to establish the relationship between the structure - solubilizing
properties of these compounds toward poorly water-soluble dyes and
the antimicrobial drug furazolidone. Aggregation number decreases
upon increasing charge of surfactant head group Dabco-surfactants.
This trend remains for all di-Dabco surfactant analogs. The deterioration
of the solubilizing properties of dicationic Dabco-surfactants toward
dyes Orange OT and Sudan I is associated with their low aggregation
numbers and looser packaging micelles. To improve the solubility of
drug (furazolidone), micellar solubilization was applied. Furazolidone
dissolves better in cationic surfactant solutions. The solubility of furazol-
idone at 5mMsurfactants is 1.2 times better in CTAB solutions, 1.4 times
better in mono-CS-16 solutions and 1.25 times better in di-CS-16 solu-
tions than inwater. The self-diffusion coefﬁcient values and aggregationnumber of di-CS-16 micelle in the absence and presence of solubilizate,
and solubilizate above CMC are almost the same. This indicates that
solubilizate does not affect the size and shape of di-CS-16 micelles. An-
timicrobial mixed compositions based on mono-Dabco-surfactant,
displaying the best solubilization properties, were made. The use of
mixed composition mono-Dabco-16/furazolidone improves not only
the solubility of drug, but also provides a signiﬁcant increase in the
level of antimicrobial activity (MIC at the value 0.48 ± 0.05 and 3.9 ±
0.4 μg.mL−1 against bacterium Staphylococcus aureus and a fungus Can-
dida albicans) and reduces the dose of each of the components in the
formulation and decreases the toxicity.
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